RETINAL SENSITIVITY AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB FOR THE TREATMENT OF MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION

被引:38
作者
Yamaike, Noritatsu [1 ]
Tsujikawa, Akitaka [1 ]
Sakamoto, Atsushi [1 ]
Ota, Masafumi [1 ]
Kotera, Yuriko [1 ]
Miyamoto, Kazuaki [1 ]
Kita, Mihori [1 ]
Yoshimura, Nagahisa [1 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Sakyo Ku, Kyoto 6068507, Japan
来源
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES | 2009年 / 29卷 / 06期
关键词
bevacizumab; branch retinal vein occlusion; central retinal vein occlusion; macular edema; optical coherence tomography; photoreceptor layer; FOVEAL PHOTORECEPTOR LAYER; ENDOTHELIAL GROWTH-FACTOR; AVASTIN TREATMENT; MICRO-PERIMETER-1; THICKNESS;
D O I
10.1097/IAE.0b013e31819d4fbf
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To evaluate the change in macular function after intravitreal injection of bevacizumab for the treatment of macular edema associated with retinal vein occlusion. Methods: For this interventional case series, 20 eyes of 20 patients with macular edema associated with retinal vein occlusion were treated with an intravitreal injection of bevacizumab. Microperimetry in the macular area was performed with a Micro Perimeter 1 before and at 1, 3, and 6 months after treatment. Results: Improvement in macular function was detected immediately after treatment and lasted for at least 6 months. As measured by the Micro Perimeter 1, mean retinal sensitivities within the central 10 degrees field (4.9 +/- 2.7 dB at baseline) improved to 7.2 +/- 3.1 dB at 1 month, to 7.6 +/- 3.4 dB at 3 months, and to 7.7 +/- 3.9 dB at 6 months (P < 0.001). Of the 20 eyes, a recurrence of macular edema was observed in 14 (70%), but with the use of optical coherence tomography, integrity of the outer aspect of the foveal photoreceptors was detected at 3 months to 6 months in 15 (75%) eyes. Conclusion: In eyes with macular edema associated with retinal vein occlusion, improvement in macular function was detected immediately after intravitreal injection of bevacizumab and lasted for at least 6 months. RETINA 29:757-767, 2009
引用
收藏
页码:757 / 767
页数:11
相关论文
共 33 条
[1]  
[Anonymous], 1984, AM J OPHTHALMOL, V98, P271
[2]   Intravitreal bevacizumab (avastin) for proliferative diabetic retinopathy: 6-months follow-up [J].
Arevalo, J. F. ;
Wu, L. ;
Sanchez, J. G. ;
Maia, M. ;
Saravia, M. J. ;
Fernandez, C. F. ;
Evans, T. .
EYE, 2009, 23 (01) :117-123
[3]   Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: A one-year prospective study [J].
Bashshur, Ziad F. ;
Haddad, Zeina A. ;
Schakal, Alexandre ;
Jaafar, Rola F. ;
Saab, Marc ;
Noureddin, Baha' N. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2008, 145 (02) :249-256
[4]   Histologic correlation of in vivo optical coherence tomography images of the human retina [J].
Chen, TC ;
Cense, B ;
Miller, JW ;
Rubin, PAD ;
Deschler, DG ;
Gragoudas, ES ;
de Boer, JF .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2006, 141 (06) :1165-1168
[5]  
Clarkson JC, 1997, ARCH OPHTHALMOL-CHIC, V115, P486
[6]  
CLARKSON JG, 1995, OPHTHALMOLOGY, V102, P1425
[7]   Optical coherence tomography 3: Delineation of the outer neural retinal boundary and its influence on retinal thickness measurements [J].
Costa, RA ;
Calucci, D ;
Skaf, M ;
Cardillo, JA ;
Castro, JC ;
Melo, LA ;
Martins, MC ;
Kaiser, PK .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 (07) :2399-2406
[8]   Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions - IBeVO study [J].
Costa, Rogerio A. ;
Jorge, Rodrigo ;
Calucci, Daniela ;
Melo, Luiz A., Jr. ;
Cardillo, Jose A. ;
Scott, Ingrid U. .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (02) :141-149
[9]   Intravitreal bevacizumab (avastin) treatment of neovascular age-related macular degeneration [J].
Emerson, M. Vaughn ;
Lauer, Andreas K. ;
Flaxel, Christina J. ;
Wilson, David J. ;
Francis, Peter J. ;
Stout, J. Timothy ;
Emerson, Geoffrey G. ;
Schlesinger, Thomas K. ;
Nolte, Susan K. ;
Klein, Michael L. .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (04) :439-444
[10]   Early bevacizumab treatment of central retinal vein occlusion [J].
Ferrara, Daniela C. ;
Koizumi, Hideki ;
Spaide, Richard F. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 144 (06) :864-871